309 related articles for article (PubMed ID: 31544046)
21. Effect of leaking perifoveal microaneurysms on resolution of diabetic macular edema treated by combination therapy using anti-vascular endothelial growth factor and short pulse focal/grid laser photocoagulation.
Hirano T; Toriyama Y; Iesato Y; Imai A; Hirabayashi K; Nagaoka T; Takamura Y; Sugimoto M; Murata T
Jpn J Ophthalmol; 2017 Jan; 61(1):51-60. PubMed ID: 27730425
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness of Intravitreal Ranibizumab in Nonvitrectomized and Vitrectomized Eyes with Diabetic Macular Edema: A Two-Year Retrospective Analysis.
Gedar Totuk OM; Kanra AY; Bromand MN; Kilic Tezanlayan G; Ari Yaylalı S; Turkmen I; Ardagil Akcakaya A
J Ophthalmol; 2020; 2020():2561251. PubMed ID: 32832135
[TBL] [Abstract][Full Text] [Related]
23. Hyperreflective foci in OCT image as a biomarker of poor prognosis in diabetic macular edema patients treating with Conbercept in China.
Liu S; Wang D; Chen F; Zhang X
BMC Ophthalmol; 2019 Jul; 19(1):157. PubMed ID: 31337360
[TBL] [Abstract][Full Text] [Related]
24. One-year outcomes of novel VEGF decoy receptor therapy with intravitreal conbercept in diabetic retinopathy-induced macular edema.
Zhou Q; Guo C; You A; Wang D; Wang W; Zhang X
Mol Vis; 2019; 25():636-644. PubMed ID: 31700228
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the effect of ranibizumab and dexamethasone implant on serous retinal detachment in diabetic macular edema.
Demircan A; Ozkaya A; Alkin Z; Kemer B; Yesilkaya C; Demir G
J Fr Ophtalmol; 2018 Oct; 41(8):733-738. PubMed ID: 30213609
[TBL] [Abstract][Full Text] [Related]
26. The Effect of Ranibizumab Loading Treatment on Vision-Related Quality of Life in Diabetic Macular Edema.
Daldal H; Turkyilmaz M; Balikoglu Yilmaz M; Berberoglu U
Clin Pract; 2021 Sep; 11(3):659-670. PubMed ID: 34563010
[TBL] [Abstract][Full Text] [Related]
27. Combined Intravitreal Ranibizumab and Sub-Tenon Injection of Triamcinolone for the Treatment of Diabetic Macular Edema with Retinal Detachment.
Ercalik NY; Yenerel NM; Imamoglu S; Kumral ET; Vural ET
J Ocul Pharmacol Ther; 2016 May; 32(4):225-9. PubMed ID: 27092435
[TBL] [Abstract][Full Text] [Related]
28. Comparison of Conbercept with Ranibizumab for the Treatment of Macular Edema Secondary to Branch Retinal Vein Occlusion.
Li F; Sun M; Guo J; Ma A; Zhao B
Curr Eye Res; 2017 Aug; 42(8):1174-1178. PubMed ID: 28441077
[TBL] [Abstract][Full Text] [Related]
29. Clinical effectiveness of ranibizumab and conbercept for neovascular age-related macular degeneration: a meta-analysis.
Wang L; Zhang C; Hua R
Drug Des Devel Ther; 2018; 12():3625-3633. PubMed ID: 30464394
[TBL] [Abstract][Full Text] [Related]
30. Photodynamic therapy in combination with ranibizumab versus ranibizumab monotherapy for polypoidal choroidal vasculopathy: A systematic review and meta-analysis.
Liu L; Tham YC; Wu J; Yue S; Cheng CY
Photodiagnosis Photodyn Ther; 2017 Dec; 20():215-220. PubMed ID: 28935532
[TBL] [Abstract][Full Text] [Related]
31. Comparison of early dexamethasone retreatment versus standard dexamethasone regimen combined with PRN ranibizumab in diabetic macular edema.
Arıkan Yorgun M; Toklu Y; Mutlu M
Int Ophthalmol; 2017 Feb; 37(1):185-196. PubMed ID: 27173834
[TBL] [Abstract][Full Text] [Related]
32. Diabetic macular edema in proliferative stage treated with anti-vascular endothelial growth factor agent and triamcinolone acetonide by laser-based strategies.
Qiao G; Dong WJ; Dai Y; Jiang ZH; Guo HK
Int J Ophthalmol; 2017; 10(7):1113-1119. PubMed ID: 28730115
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and Safety of Aflibercept Therapy for Diabetic Macular Edema: A Systematic Review and Meta-Analysis.
Santhakumaran S; Salimi A; Brunetti VC; Galic J
J Curr Ophthalmol; 2022; 34(2):133-147. PubMed ID: 36147265
[TBL] [Abstract][Full Text] [Related]
34. Comparative Efficacy of Anti-vascular Endothelial Growth Factor (Anti-VEGF) Agents and Corticosteroids in Managing Diabetic Retinopathy-Associated Diabetic Macular Edema: A Meta-Analysis and Comprehensive Systematic Review.
Kumar A; Kumar A; Kumar J; Bai G; Jeewnani R; Dembra M; Kanwal K; Qadeer U; Khawar MH; Yaseen Khan I; Ram R; Varrassi G
Cureus; 2024 Jan; 16(1):e51910. PubMed ID: 38333510
[TBL] [Abstract][Full Text] [Related]
35. Predictive factors of better outcomes by monotherapy of an antivascular endothelial growth factor drug, ranibizumab, for diabetic macular edema in clinical practice.
Sato S; Shinoda H; Nagai N; Suzuki M; Uchida A; Kurihara T; Kamoshita M; Tomita Y; Iyama C; Minami S; Yuki K; Tsubota K; Ozawa Y
Medicine (Baltimore); 2017 Apr; 96(16):e6459. PubMed ID: 28422835
[TBL] [Abstract][Full Text] [Related]
36. Comparison of Efficacy and Safety between Conbercept and Ranibizumab in Neovascular Age-Related Macular Degeneration: A Meta-Analysis of Randomized Controlled Trials.
Wang X; Yu C; Yang J; Liu Y; Xu Y; Li W
Ophthalmic Res; 2022; 65(2):140-151. PubMed ID: 34583363
[TBL] [Abstract][Full Text] [Related]
37. Intravitreal Conbercept with Grid/Focal Photocoagulation for the Treatment of Diabetic Macular Edema: A Systematic Review and Meta-Analysis.
Sun X; Wei W
J Ophthalmol; 2022; 2022():2256779. PubMed ID: 35251705
[TBL] [Abstract][Full Text] [Related]
38. Comparisons of Efficacy of Intravitreal Aflibercept and Ranibizumab in Eyes with Diabetic Macular Edema.
Shimizu N; Oshitari T; Tatsumi T; Takatsuna Y; Arai M; Sato E; Baba T; Yamamoto S
Biomed Res Int; 2017; 2017():1747108. PubMed ID: 28758110
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of intravitreal faricimab for neovascular age-related macular degeneration: a systematic review and meta-analysis.
Yen WT; Wu CS; Yang CH; Chen YH; Lee CH; Hsu CR
Sci Rep; 2024 Jan; 14(1):2485. PubMed ID: 38291069
[TBL] [Abstract][Full Text] [Related]
40. Bevacizumab for macular edema secondary to retinal vein occlusion: a systematic review and meta-analysis.
Lu Y; Su L; Xu X
J Ocul Pharmacol Ther; 2013 Oct; 29(8):702-8. PubMed ID: 23746130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
